Partnering with great companies to drive growth

The right partner changes everything

We build great companies and create lasting value.
It’s all about partnership and collaboration, built on a foundation of trust and transparency. Our team leverages deep sector knowledge and operating expertise to drive a shared vision for success.

See how

Our funds

Over nearly 50 years, our team has raised $35 billion of equity capital, worked with over 170 partner companies around the world and fueled more than 600 add-on acquisitions representing an aggregate enterprise value of over $250 billion.

Flagship funds

THL is currently investing from Fund IX, the firm’s ninth flagship fund. We partner with companies in 17 identified sectors across three industry verticals: Financial Technology & Services, Healthcare and Technology & Business Solutions.

Learn more

Automation fund

THL’s Automation Fund helps companies drive digital transformation across diverse end markets—from agriculture and semiconductor manufacturing, to healthcare and eCommerce. Our automation partners work to address important societal challenges and unlock economic opportunity around the globe

Learn more

I’m interested in learning more about

  • Financial Technology & Services (FTS)
  • Healthcare (HC)
  • Technology & Business Solutions (TABS)
  • Automation

Latest

2023 Healthcare Trends and Our Outlook for 2024
Insights
2023 Healthcare Trends and Our Outlook for 2024 

Operational Challenges, Patent Cliffs & Biotech Funding Slowdown, and Generative AI Define 2023; Encouraging Prospects Emerge for 2024 Key Takeaways: The healthcare industry experienced a significant transformation in 2023, driven by three defining trends: operational challenges due to staffing shortages and evolving payment models, looming patent cliffs for pharma manufacturers and a biotech funding slowdown that impacted

Healthcare (HC)
<strong>Thomas H. Lee Partners Appoints Former Willis Towers Watson CEO John Haley as an Executive Partner of Financial Technology & Services Investment Group</strong>
Press Release
Thomas H. Lee Partners Appoints Former Willis Towers Watson CEO John Haley as an Executive Partner of Financial Technology & Services Investment Group 

Haley Appointed to Board of AmeriLife Group, LLC BOSTON–(BUSINESS WIRE)–Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in middle-market growth companies, today announced the appointment of former Willis Towers Watson CEO John Haley as an Executive Partner in the firm’s Financial Technology and Services investment group. Haley has also been appointed to the
AmeriLife Announces Strategic Investment from Genstar Capital
Press Release
AmeriLife Announces Strategic Investment from Genstar Capital 

Renowned private equity firm’s joint partnership with Thomas H. Lee Partners will expand AmeriLife’s suite of services and offerings, and further accelerate growth for the nation’s leading distributor of health and financial solutions CLEARWATER, Fla., June 13, 2022 /PRNewswire/ —  AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning
2023 Healthcare Trends and Our Outlook for 2024
Insights
2023 Healthcare Trends and Our Outlook for 2024 

Operational Challenges, Patent Cliffs & Biotech Funding Slowdown, and Generative AI Define 2023; Encouraging Prospects Emerge for 2024 Key Takeaways: The healthcare industry experienced a significant transformation in 2023, driven by three defining trends: operational challenges due to staffing shortages and evolving payment models, looming patent cliffs for pharma manufacturers and a biotech funding slowdown that impacted

Healthcare (HC)
The Future of Pharmaceuticals: How Technology, Big Data, and AI May Help Speed Drug Development
Insights
The Future of Pharmaceuticals: How Technology, Big Data, and AI May Help Speed Drug Development 

A Recap of THL’s Pharma Technology Panel | Fall 2023 Key Takeaways: The pharmaceutical industry is undergoing a digital transformation driven by emerging technology, data proliferation, and artificial intelligence (AI). AI is playing a pivotal role in clinical trials by handling complex tasks and analyzing massive health data sets with speed and precision to ultimately improve the efficiency

Healthcare (HC)
<strong>Intelligent Medical Objects Announces the Acquisition of Melax Technologies Inc.</strong>
Press Release
Intelligent Medical Objects Announces the Acquisition of Melax Technologies Inc. 

Acquisition to expand IMO’s suite of products to improve patient care, clinical workflows, and healthcare data quality CHICAGO–(BUSINESS WIRE)–Intelligent Medical Objects (IMO), a leading provider of clinical terminology management and data quality solutions for healthcare, announced today that it has acquired Melax Technologies, Inc. (Melax Tech). Melax Tech empowers the healthcare and life sciences industries through use of Artificial
Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group
Press Release
Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group 

BOSTON, Massachusetts, October 11, 2022 – Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm’s healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology (“Healthcare IT”), will support the team’s efforts in identifying, sourcing, and growing investment opportunities across the healthcare market. “We
<strong>Intelligent Medical Objects Announces the Acquisition of Melax Technologies Inc.</strong>
Press Release
Intelligent Medical Objects Announces the Acquisition of Melax Technologies Inc. 

Acquisition to expand IMO’s suite of products to improve patient care, clinical workflows, and healthcare data quality CHICAGO–(BUSINESS WIRE)–Intelligent Medical Objects (IMO), a leading provider of clinical terminology management and data quality solutions for healthcare, announced today that it has acquired Melax Technologies, Inc. (Melax Tech). Melax Tech empowers the healthcare and life sciences industries through use of Artificial
<strong>Bynder Announces Majority Investment from Thomas H. Lee Partners</strong>
Press Release
Bynder Announces Majority Investment from Thomas H. Lee Partners 

Partnership will support continued product innovation and customer growth AMSTERDAM–(BUSINESS WIRE)–Bynder (“the company”), a global leader in Digital Asset Management (DAM), today announced that it will receive a majority investment from Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in growth companies. The partnership will accelerate Bynder’s ability to help brands overcome the complexity of
Inriver Announces Growth Investment from Thomas H. Lee Partners
Press Release
Inriver Announces Growth Investment from Thomas H. Lee Partners 

Investment will support continued product innovation and go-to-market expansion in key markets of North America and Europe MALMÖ, Sweden and CHICAGO, May 19, 2022 /PRNewswire/ — Inriver (“the Company”), a company that empowers organizations to deliver revenue-driving product information management (PIM) across every customer touchpoint, today announced that it will receive a majority investment from Thomas H. Lee Partners, L.P. (THL), a premier private equity firm investing in growth companies. Verdane, the
<strong>Bynder Announces Majority Investment from Thomas H. Lee Partners</strong>
Press Release
Bynder Announces Majority Investment from Thomas H. Lee Partners 

Partnership will support continued product innovation and customer growth AMSTERDAM–(BUSINESS WIRE)–Bynder (“the company”), a global leader in Digital Asset Management (DAM), today announced that it will receive a majority investment from Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in growth companies. The partnership will accelerate Bynder’s ability to help brands overcome the complexity of

Want to know more?

Let’s explore how we can collaborate with your company.

Get in touch